Apogee Therapeutics, Inc. (APGE) Free cash flow 2023–2025
Apogee Therapeutics, Inc. (APGE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$232.6MFY2025 · since FY2023: -$74.9M → -$232.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$232.6M | -35.0% |
| FY2024 | -$172.3M | -130.0% |
| FY2023 | -$74.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice